When studying known oncogenes such as EGFR, PTEN and CIC at a gene level (Fig. 8), as expected, we observe high number of mutations, high number of gene fusions, amplified gene expression values and copy number gains for EGFR across IDH-wt GBM. This evidence concerns the gene PTEN and glioblastoma.